Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for proteinuria in type 2 diabetic patients
IRCT201010144941N1Phase 4Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pentoxifylline in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis, sponsored by Babol University of Medical Sciences. Primary endpoint: Change in proteinuria. Started Nov 2010; status: completed.
02
Drugs
pentoxifylline
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on IRCT201010144941N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201010144941N1.